Text and Data Mining valid from 2019-03-04
First Online: 4 March 2019
Compliance with Ethical Standards
: Pam R. Taub has no disclosures related to this paper. However, she is a consultant and speaker for Sanofi/Regeneron, Novo-Nordisk, Boehringer-Ingleheim, Janssen, Pfizer, Amarin, and Amgen. She is a stock holder of Cardero Therapeutics. She is also medical director of the Ornish/ICR program at UC San Diego Health System.Hannah C. Lo declares no conflict of interest.Andrew M. Freeman does non-promotional speaking for Boehringer-Ingleheim. He is also medical director of the Ornish/ICR program at National Jewish Health.Dean Ornish receives royalties from books, fees from Sharecare, and sometimes honoraria from lecturing.
: This article does not contain any studies with human or animal subjects performed by any of the authors. It is a review article summarizing previously published human studies.